Physician profile
Martin A Korkowski
NPI 1801880752
$1,770.74
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $951 · 2020: $277 · 2021: $140 · 2022: $96.74 · 2023: $169 · 2024: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $306.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $445.03 | 2019-2024 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $206.09 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $160.51 | 2019-2023 | Jardiance, Tradjenta |
| Abbvie INC. | $126.18 | 2020-2023 | |
| Astrazeneca Pharmaceuticals LP | $105.27 | 2019-2024 | Breztri |
| Kowa Pharmaceuticals America, INC. | $97.62 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $90.37 | 2019 | |
| Amarin Pharma, INC. | $89.80 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $81.89 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $69.93 | 2019 | |
| Allergan, INC. | $56.10 | 2019-2020 | |
| Lilly USA, LLC | $44.24 | 2020-2024 | Jardiance |
| Exact Sciences Corporation | $39.43 | 2023-2024 | Cologuard Collection Kit |
| Amgen INC. | $38.40 | 2019 | |
| Glaxosmithkline, LLC. | $33.18 | 2023-2024 | Arexvy, Trelegy Ellipta, Shingrix |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $25.56 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $19.82 | 2019 | |
| Genentech USA, INC. | $16.16 | 2019 | |
| Alexion Pharmaceuticals, INC. | $13.46 | 2020 | |
| Owp Pharmaceuticals, INC. | $11.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Korkowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.